What This Means
This research suggests that a protein called GDF-15, measured in the blood shortly after a stroke, is linked to the later development of post-stroke depression (PSD) — a common and serious complication affecting stroke survivors. In a study of 302 patients admitted after acute ischemic stroke, 100 (about one-third) went on to develop depression. Patients who developed PSD tended to be older, have more severe strokes, have a family history of psychiatric illness, and have higher blood levels of several inflammatory and neurological markers, including GDF-15, IL-6, and neurofilament light chain (NfL).
Using statistical modeling, the researchers identified six independent risk factors for post-stroke depression: stroke severity (measured by NIHSS score), family history of psychiatric disorders, infarction in the frontal lobe of the brain, and elevated levels of IL-6, NfL, and GDF-15. These six factors were combined into a nomogram — a visual clinical prediction tool — that achieved an AUC of 0.863, indicating strong ability to distinguish patients who will develop PSD from those who will not.
This research suggests that measuring GDF-15 alongside other clinical information at hospital admission could help clinicians identify stroke patients at high risk of developing depression, potentially enabling earlier monitoring or intervention. The combination of inflammatory markers, neurological injury markers, stroke location, and patient history appears to capture multiple biological pathways involved in post-stroke depression development.